Correlation Between Neurocrine Biosciences and Hepion Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurocrine Biosciences and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Neurocrine Biosciences and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Hepion Pharmaceuticals.

Diversification Opportunities for Neurocrine Biosciences and Hepion Pharmaceuticals

0.23

Correlation Coefficient

Neurocrine Biosciences  Hepion Pharmaceuticals

Modest diversification

The 3 months correlation between Neurocrine and Hepion is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Hepion Pharmaceuticals go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Hepion Pharmaceuticals

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 2.36 times less return on investment than Hepion Pharmaceuticals. But when comparing it to its historical volatility, Neurocrine Biosciences is 3.85 times less risky than Hepion Pharmaceuticals. It trades about 0.21 of its potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  57.00  in Hepion Pharmaceuticals on August 13, 2024 and sell it today you would earn a total of  10.00  from holding Hepion Pharmaceuticals or generate 17.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Neurocrine Biosciences  vs.  Hepion Pharmaceuticals

Neurocrine Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neurocrine Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Hepion Pharmaceuticals

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Hepion Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Hepion Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neurocrine Biosciences and Hepion Pharmaceuticals

The main advantage of trading using opposite Neurocrine Biosciences and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.

The idea behind Neurocrine Biosciences and Hepion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.